Journal of Clinical Immunology

, Volume 13, Issue 5, pp 329–338 | Cite as

Anti-“dividing cell antigen” autoantibody: A novel antinuclear antibody pattern related to histones in systemic lupus erythematosus

  • Martin Blaschek
  • Sylviane Muller
  • Pierre Youinou
Original Articles


This study aims to describe a novel antinuclear antibody directed to proteins only accessible during the mitosis: anti-“dividing cell antigen” (DCA) antibody. A total of 709 disease-associated and control sera was tested by indirect immunofluorescence using a variety of cell lines as substrate. Cells were treated with enzymes and antibodies absorbed with nuclear antigens. Antibodies to DNA, histone subfractions, and synthetic peptides were evaluated using enzyme-linked immunosorbent assays. Cell extracts were electrophoresed before and after synchronization and sera tested on the blots. The anti-DCA antibody was demonstrated in 10 of 183 SLE patients but virtually never in other connective tissue diseases. The DCA was sensitive to HCl and proteolytic enzymes and the anti-DCA binding inhibited by histones H2A and H2B. Differences of anti-H2A and anti-H2B were observed between anti-DCA antibody-positive and anti-DCA antibody-negative sera, and antibodies specific for the 1–15 region of H2A, the 1–25 region of H2B and the 1–29 region of H4 were more frequent in the former sera than in the latter. The anti-DCA antibody was shown to react with a 60-kDa protein. Our findings suggest that the anti-DCA antibody is directed to a protein complex containing H2A and H2B.

Key words

Antinuclear antibody histone systemic lupus erythematosus 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Fritzler MJ: Autoantibody testing: Procedures and significance in systemic rheumatic diseases. Meth Achiev Exp Pathol 1:224–260, 1986Google Scholar
  2. 2.
    Tan EM, Chan EKL, Sullivan KF, Rubin RL: Antinuclear antibodies: Diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity. Clin Immunol Immunopathol 47:124–141, 1988Google Scholar
  3. 3.
    Tan EM: Antinuclear antibodies: Diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 44:93–151, 1989Google Scholar
  4. 4.
    van Venrooij WJ, Sillekens PTJ: Small nuclear RNA associated proteins: Autoantigens in connective tissue diseases. Clin Exp Rheumatol 7:635–645, 1989Google Scholar
  5. 5.
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Green Schaller J, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arth Rheum 25:1271–1277, 1982Google Scholar
  6. 6.
    Miyachi K, Fritzler MJ, Tan EM: Autoantibody to a nuclear antigen in proliferating cells. J Immunol 121:2228–2234, 1978Google Scholar
  7. 7.
    Price CM, McCarty GA, Petitjohn DE: NuMA protein is a human autoantigen. Arth Rheum 27:774–779, 1984Google Scholar
  8. 8.
    Barque JP, Danon F, Peraudeau L, Yeni P, Larsen CJ: Characterization by human autoantibody of a nuclear antigen related to the cell cycle. EMBO J 2:743–749, 1983Google Scholar
  9. 9.
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arth Rheum 31:315–324, 1987Google Scholar
  10. 10.
    Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (Scleroderma). Arth Rheum 21:581–590, 1980Google Scholar
  11. 11.
    Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, Coll Daroca J, de Vita S, Drosos AA, Hatron PY, Hay E, Isenberg DA, Janin A, Kalden JR, Kater L, Konttinen YT, Maddison PJ, Maini RN, Manthorpe R, Meyer O, Ostuni P, Pennec YL, Prause JU, Richards A, Sauvezie B, Schiodt M, Sciuto M, Scully C, Shoenfeld Y, Skopouli FN, Smolen JS, Snaith ML, Tincani A, Tishler M, Todesco S, Valesini G, Venables PJW, Wattiaux MJ, Youinou P: Diagnostic criteria for Sjögren's syndrome. Results of a European multicentre study. Arth Rheum 36:340–347, 1933Google Scholar
  12. 12.
    Gentric A, Blaschek M, Le Noach'h JF, Johanet C, Jouquan J, Lamour A, Abuaf N, Pennec YL, Youinou P: Serological arguments for classifying Raynaud's phenomenon as idiopathic. J Rheumatol 17:1177–1181, 1990Google Scholar
  13. 13.
    Johns EW: Studies on histones. 1964. Preparative methods for histone fractions from calf thymus. Biochem J 92:55–59, 1964Google Scholar
  14. 14.
    Michalski-Scrive C, Aubert JP, Couppez M, Biserte G, Loucheux-Lefebvre MH: UV differential study of the histones H2A-H2B-H3-H4 Octamer. Biochimie 64:347–355, 1982Google Scholar
  15. 15.
    Muller S, Chaix ML, Briand JP, van Regenmortel MHV: Immunogenicity of free histones and of histones complexed with RNA. Mol Immunol 28:763–772, 1991Google Scholar
  16. 16.
    Barany G, Merrifield RB: Solid-phase peptide synthesis.In The Peptides, E Gross, J Meinenhofer (eds). New York, Academic Press, 1980, pp 1–284.Google Scholar
  17. 17.
    Plaué S, Briand JP: Solid-phase peptide synthesis.In Synthetic Polypeptides as Antigens, RH Burdon, PH van Knippenberg (eds). Amsterdam, Elsevier, 1988, pp 41–94Google Scholar
  18. 18.
    Youinou P, Mackenzie L, Katsikis P, Merdrignac G, Isenberg DA, Tuaillon N, Lamour A, Le Goff P, Jouquan J, Drogou A, Muller S, Genetet B, Moutsopoulos HM, Lydyard PM: The relationship between CD5-expressing B lymphocytes and serologic abnormalities in rheumatoid arthritis patients and their relatives. Arth Rheum 33:339–348, 1990Google Scholar
  19. 19.
    Sieve GW, Turnbull D, Mullins JM, McIntosh JR: Production of large numbers of mitotic mammalian cells by use of the reversible microtubule inhibitor nocodazole. Exp Cell Res 126:391–405, 1980Google Scholar
  20. 20.
    Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685, 1970Google Scholar
  21. 21.
    Stollar BD: Reaction of systemic lupus erythematosus sera with histone fractions and histones-DNA complexes. Arth Rheum 14:485–492, 1971Google Scholar
  22. 22.
    Fritzler MJ, Tan EM: Antibodies to histones in drug-induced and idiopathic lupus erythematosus. J Clin Invest 62:560–567, 1978Google Scholar
  23. 23.
    Muzellec Y, Le Goff P, Jouquan J, Fauquert P, Muller S, Youinou P: Antibodies to histones in rheumatoid arthritis. Diagn Clin Immunol 5:326–331, 1988Google Scholar
  24. 24.
    Pauls JD, Silverman E, Laxer RM, Fritzler MJ: Antibodies to histones H1 and H5 in sera of patients with juvenile rheumatoid arthritis. Arth Rheum 32:326–331, 1989Google Scholar
  25. 25.
    Thomas JO, Wilson CM, Hardin JA: The major core histone antigenic determinants in systemic lupus erythematosus are in the trypsin-sensitive regions. FEBS Lett 169:90–96, 1984Google Scholar
  26. 26.
    Muller S, Bonnier D, Thiry M, van Regenmortel MHV: Reactivity of autoantibodies in systemic lupus erythematosus with synthetic core histone peptides. Int Arch Allergy Appl Immunol 89:288–296, 1988Google Scholar
  27. 27.
    Ogata K, Ogata Y, Takasaki U, Tan EM: Epitopes on proliferating cell nuclear antigen recognized by human lupus autoantibody and murine monoclonal antibody. J Immunol 139:2942–2946, 1987Google Scholar
  28. 28.
    Hershko A: Ubiquitin-mediated protein degradation. J Biol Chem 263:15237–15240, 1988Google Scholar
  29. 29.
    Habets WJ, Berden JHM, Hoch SO, van Vanroiij WJ: Further characterization and subcellular localization of Sm and U1 ribonucleoprotein antigens. Eur J Immunol 15:992–997, 1985Google Scholar
  30. 30.
    Bini P, Chu JM, Okolo C, Elkon K: Analysis of autoantibodies to recombinant La(SS-B) peptides in systemic lupus erythematosus and primary Sjögren's syndrome. J Clin Invest 85:325–333, 1990Google Scholar
  31. 31.
    Earnshaw WC, Sullivan KF, Machlin PS, Cooke CA, Kaiser DA, Pollar TD, Rothfield NF, Cleveland DW: Molecular cloning of CDNA for CENP-B, the major human centromere auto-antigen. J Cell Biol 104:817–829, 1987Google Scholar
  32. 32.
    Muller S, Mazen A, Martinage A, van Regenmortel MHV: Use of histone antibodies for studying chromatin topography and the phosphorylation of chromatin subunits. EMBO J 3:2431–2436, 1984Google Scholar
  33. 33.
    Butler PJG: The folding of chromatin. CRC Crit Rev Biochem 15:57–91, 1983Google Scholar
  34. 34.
    Chaly N, Bladon T, Setterfield G, Little JE, Kaplan JG, Brown DL: Changes in distribution of nuclear matrix antigens during the mitotic cell cycle. J Cell Biol 99:661–671, 1984Google Scholar
  35. 35.
    Muller S, Briand JP, van Regenmortel MHV: Presence of antibodies to ubiquitin during the autoimmune response associated with systemic lupus erythematosus. Proc Natl Acad Sci USA 85:8176–8180, 1988Google Scholar
  36. 36.
    Tan EM: Interactions between autoimmunity and molecular and cell biology. Bridges between clinical and basic sciences. J Clin Invest 84:1–6, 1989Google Scholar

Copyright information

© Plenum Publishing Corporation 1993

Authors and Affiliations

  • Martin Blaschek
    • 1
  • Sylviane Muller
    • 2
  • Pierre Youinou
    • 3
  1. 1.Laboratory of ImmunologyBrest University Medical School HospitalBrestFrance
  2. 2.Institute of Molecular and Cellular Biology, CNRSStrasbourgFrance
  3. 3.Laboratoire d'Immunologie, CHUBrest CedexFrance

Personalised recommendations